XML 58 R48.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2017
Defined Benefit Plan Disclosure [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross 100,000 3,245,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 0.51 $ 0.50  
Stock options, exercised 450,000 950,000  
Stock-based compensation expense $ 992,735 $ 257,557  
Deferred compensation expense $ 2,565,244    
Incentive Stock      
Defined Benefit Plan Disclosure [Line Items]      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross 100,000 3,245,000  
Stock options, exercised 75,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value $ 0.18    
[custom:IncentiveStockOptionGrantsAdditionalInformation]   Each independent Board member was granted 25,000 shares in the first and second quarter of 2023, for a total of 50,000 shares each. Three (3) key employees were granted a total of 2,050,000 share options. An independent member of the Board of Directors was granted 750,000 share options, and a total of 345,000 share options were granted among nine (9) employees. During the year ended December 31, 2023, 200,000 shares were exercised by two (2) independent members of the Board of Directors. During the year ended 2023, 700,000 partially vested share options were forfeited by two (2) key employees of the Company. The Aggregate Intrinsic Value is based on the market value of the Company’s common stock of $0.89 on December 31, 2023.  
Sole Shareholder      
Defined Benefit Plan Disclosure [Line Items]      
Stock Issued During Period, Shares, Acquisitions     13,500,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross     1,500,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price     $ 0.22
Chief Executive Officer      
Defined Benefit Plan Disclosure [Line Items]      
Stock options, exercised 375,000    
Shares issued as a result of options exercised 375,000    
Stock price $ 0.22    
Shares options, expiration extended expiration dates on his last two (2) 187,500 share option tranches by one (1) year, or to respectively expire at midnight on September 17, 2025, and December 17, 2025